Cracking the Code: Understand and Profit from the Biotech Revolution That Will Transform Our Lives and Generate Fortunes

Cracking the Code: Understand and Profit from the Biotech Revolution That Will Transform Our Lives and Generate Fortunes

Hardback

By (author) Jim Mellon, By (author) Al Chalabi

$22.49
List price $26.54
You save $4.05 15% off

Free delivery worldwide
Available
Dispatched in 3 business days
When will my order arrive?

  • Publisher: John Wiley & Sons Inc
  • Format: Hardback | 360 pages
  • Dimensions: 138mm x 222mm x 30mm | 558g
  • Publication date: 22 May 2012
  • Publication City/Country: New York
  • ISBN 10: 1119963184
  • ISBN 13: 9781119963189
  • Edition: 2
  • Illustrations note: Illustrations, map
  • Sales rank: 240,162

Product description

Everything you need to know about the most important trend in the history of the world Within most people's lifetimes, the developments in the biotechnology sector will allow us to live increasingly long and healthy lives, as well as provide us with technological innovations that will transform the way we live. But these innovations offer more than just hope for a better life, but hope for better returns too. Financial returns of incredible magnitude await savvy investors and businesspeople who can see the massive changes on the horizon. This book details these fast-moving trends and innovations and offers extensive advice on how to profit from them in business and investing.

Other people who viewed this bought:

Showing items 1 to 10 of 10

Other books in this category

Showing items 1 to 11 of 11
Categories:

Back cover copy

WAKE UP TO THE MOST IMPORTANT TREND IN THE HISTORY OF THE WORLDThere is a new gold rush on. The Single biggest trend to affect mankind is here, and there are fortunes to be made.The next phase in the world's development will not be dominated by the rise of China or India, or by green technologies, important though they are. Rather the world as we know it is about to be transformed by breakthrough achievements in human life extension and improvement. Entire industries are soon to be disrupted by developments in Biotechnology. And there are unparalleled opportunities for early investors to profit.This amazing acceleration in technological development is coming under the radar for many, but will soon prove to be more important to the human race than the internet, iPads, smartphones and all the other material goods we regard as technology. The fusion of technology and medicine will enable us to live longer and healthier lives with a considerably superior quality of life.LEARN, DIGEST, INFORM AND INVEST"Cracking the Code" is the first book to explore with full clarity the implications of an industry that will define the 21st century and to outline the huge returns to be had for those who invest in the companies behind these products and the changing demographic that his technology will bring about.Leading investment experts Jim Mellon and Al Chalabi have spent a year immersed in the life sciences industry, researching and interviewing over 100 companies. Writing not as scientists but as investors, they strip away the technical jargon and demystify the information to help you to understand the science and clearly identify the key industry participants and investment opportunities.The first authors to forecast an economic crisis, as early as 2005 in their book" Wake Up!," show you how the biotech industry's biggest successes will dwarf the current colossi of the stock markets. May you live long and prosper from it.

Table of contents

Acknowledgements ix Introduction xi Chapter One Transformational Technologies 1 Futurists and Scientists Look into the Future 1 The Convergence of Technology and Biology 13 Chapter Two The Evolution of Medicine and the Emergence of Biopharma 23 From Atoms to Cells to Living Organisms 24 The History of the Pharmaceutical Industry 36 Chapter Three The Drug Industry -- Reinventing the Model 55 Big Pharma, Biopharma 59 Drug Patents 73 The Path to Riches: FDA Approval 79 In Summary 84 Chapter Four Curing Disease -- Promising Prospects in the Main Therapeutic Areas 87 Cancer -- Step by Step, Being Beaten 89 Infectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector 107 Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease 118 The Heart of the Matter -- Biggest Killer on the Prowl 128 Fading into the Night -- Neurodegeneration, Rheumatology and Multiple Sclerosis 132 Respiratory Disease -- New Drugs: A Breath of Fresh Air 143 Rare Diseases and Rare Profits 146 Drugs for Pain and for the Central Nervous System 150 The Best of the Rest -- Ophthalmology, Dermatology, Gastrointestinal and Bone Disease 153 Chapter Five Turning Back the Clock -- Stem Cells, Genomics, Gene Therapy and Regeneration 157 Stem Cells 166 Gene Therapy and Nano Medicine 170 Organ Growth in and out of the Body 178 Chapter Six Demographic Changes 181 The Working Age Labour Pool in the World is Shrinking 191 Can Immigration Solve the Labour Shortage in the Developed World? 193 The Social Impact of an Ageing Population 195 The United States is the Best Positioned Developed Country 196 Support Ratios Have Been Plummeting 197 China's Grey Future 198 What Can Governments Do To Avoid Their Country Becoming a Nursing Home? 200 Chapter Seven Bioscience's Disruptive Influences 205 Insurance and Healthcare 206 Real Estate 210 Politics 211 Geopolitics 211 Retail Goods and Services 212 The Food Industry 213 The Investment Industry 214 The Law 215 Shortage of Young People in Developed Nations 217 Chapter Eight Robotics and Nanotechnology 219 Robotics 219 Surgical Procedures/Surgical Assistance 220 Medical Monitor/Nurse 223 Housemaid/Domestic Assistance 228 Companion/Pet 229 Nanotechnology 232 Chapter Nine Lifestyle Maintenance 235 It's a Fact: Obesity Shortens Your Life 235 Extending Life Expectancy 237 Common Traits of People who Live the Longest 239 A "Cure" to Ageing 240 Telomeres -- Our Biological Clock 244 Chapter Ten Investment in Biopharma -- Chasing Those Money Fountains 247 Conservative Portfolio 279 Balanced Portfolio 280 Speculative Portfolio 281 Company Overviews 282 Summary 305 Glossary 315 Appendix -- Key Financial Charts of Big Pharma 325 References 327 Bibliography 329 Index 331